top of page
Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
Goshua G, Lee AI
New England Journal of Medicine
March
2026
Utilization patterns of hematology consultation in the intensive care unit: an 11-year single-center experience
Allen C, Streiff M, Naik RP, Seam N, Kadri SS, Lee AI, Knauert M, Goshua G.
Blood Advances
March
2026
Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding
Wang D, Sra M, Ito S, Ng DQ, Glaeser-Khan S, Wang DY, Hirniak S, Lee AI, Cuker A, Goshua G
Blood Advances
March
2026
Understanding risk-deleted disability-adjusted life-years: what's left behind
Goshua G, Wang D, Ito S, Ng DQ, Pandya A.
JACC
December
2025
A threshold inequality aversion parameter (TIAP) approach to interpret distributional cost-effectiveness analysis results
Pandya A, Zhu J, Luviano A, James LP, Goshua G
Value in Health
October
2025
Hydroxyurea Therapy in Sickle Cell Disease: Evaluating Healthcare Costs and Utilization in a Brazilian Tertiary Setting
Browne LLA, do Nascimento EM, Moura P, Fidlarczyk D, Duran J, Barbosa R, Oliveira T, Goshua G, Hankins JS, Lobo C.
Blood Global Hematology
October
2025
Cost-effectiveness of upfront vs. delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML
Alhajahjeh A, Patel K, Podoltsev NA, Kewan T, Stempel JM, Mendez LM, Seropian SE, Gowda L, Huntington SF, Stahl MF, Zeidan AM, Goshua G* and Bewersdorf JP*
Blood Advances
October
2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Pine A, Butt A, Andreoli L, Knight JS, Gerosa M, Cecchi I, Branch DW, Lopez-Pedrera R, Belmont HM, Kello N, Petri M, Cervera R, Pengo V, Meroni PL, Cohen H, Willis R, Bertolccini ML, Goshua G, Gu S, Hwa J, Lee AI, Erkan D, Sharda AV
Frontiers in Immunology
October
2025

Featured Publications (5)

All Selected Publications

Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
Goshua G, Lee AI
New England Journal of Medicine
2026
March
RECOGNITIONS:

​

​

PRACTICAL IMPACT:
Utilization patterns of hematology consultation in the intensive care unit: an 11-year single-center experience
Allen C, Streiff M, Naik RP, Seam N, Kadri SS, Lee AI, Knauert M, Goshua G.
Blood Advances
2026
March
RECOGNITIONS:

​

​

PRACTICAL IMPACT:
Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding
Wang D, Sra M, Ito S, Ng DQ, Glaeser-Khan S, Wang DY, Hirniak S, Lee AI, Cuker A, Goshua G
Blood Advances
2026
March
RECOGNITIONS:

​

​

PRACTICAL IMPACT:
Understanding risk-deleted disability-adjusted life-years: what's left behind
Goshua G, Wang D, Ito S, Ng DQ, Pandya A.
JACC
2025
December
RECOGNITIONS:

​

​

PRACTICAL IMPACT:
A threshold inequality aversion parameter (TIAP) approach to interpret distributional cost-effectiveness analysis results
Pandya A, Zhu J, Luviano A, James LP, Goshua G
Value in Health
2025
October
RECOGNITIONS:

​

​

PRACTICAL IMPACT:
Hydroxyurea Therapy in Sickle Cell Disease: Evaluating Healthcare Costs and Utilization in a Brazilian Tertiary Setting
Browne LLA, do Nascimento EM, Moura P, Fidlarczyk D, Duran J, Barbosa R, Oliveira T, Goshua G, Hankins JS, Lobo C.
Blood Global Hematology
2025
October
RECOGNITIONS:

​

​

PRACTICAL IMPACT:
Cost-effectiveness of upfront vs. delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML
Alhajahjeh A, Patel K, Podoltsev NA, Kewan T, Stempel JM, Mendez LM, Seropian SE, Gowda L, Huntington SF, Stahl MF, Zeidan AM, Goshua G* and Bewersdorf JP*
Blood Advances
2025
October
RECOGNITIONS:

​

​

PRACTICAL IMPACT:
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Pine A, Butt A, Andreoli L, Knight JS, Gerosa M, Cecchi I, Branch DW, Lopez-Pedrera R, Belmont HM, Kello N, Petri M, Cervera R, Pengo V, Meroni PL, Cohen H, Willis R, Bertolccini ML, Goshua G, Gu S, Hwa J, Lee AI, Erkan D, Sharda AV
Frontiers in Immunology
2025
October
RECOGNITIONS:

​

​

PRACTICAL IMPACT:

Prophylactic weekly efanesoctocog alfa versus standard-care factor VIII in people living with severe hemophilia A: a cost-effectiveness analysis

Ito S, Potnis KC, Harvey JP, Sra M, Bewersdorf JP, Bona RD, Krumholz HM, Cuker A, Pandya A, Goshua G.
Annals of Internal Medicine
2025
June
FEATURED
RECOGNITIONS:

Gap: First conventional and distributional cost-effectiveness analysis in the care of people living with hemophilia A (Yale-HSPH-Mayo-Penn collaboration). ASH Abstract Achievement Award (S. Ito).

PRACTICAL IMPACT:

Cost-effectiveness of Lynch syndrome screening in colorectal cancer: universal germline vs sequential screening

Ito S, Xicola RM, Sra M, Potnis KC, Singh V, Gershkovich P, Stites E, Gibson J, Krumholz HM, Llor X, Goshua G
Clinical Gastroenterology & Hepatology
2025
April
FEATURED
RECOGNITIONS:

Gap: Real-world diagnostic attrition leads to missed diagnoses of inherited Lynch syndrome in probands with colorectal cancer (CRC) and their relatives. Health economic rationale for upfront germline tumor testing in probands to improve population health.

PRACTICAL IMPACT:

Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women

Wang D, Sra M, Glaeser-Khan S, Wang DY, Moshashaian-Asl R, Ito S, Cuker A, Goshua G
American Journal of Hematology
2025
April
FEATURED
RECOGNITIONS:

Gap: First cost-effectiveness analysis of ferritin screening thresholds in the care of people living with iron deficiency (Yale-Mayo-Vermont-Penn collaboration). 2024 ASH Press Program Selection, 2025 Highlights of ASH, ASH Abstract Achievement Award (D. Wang).

PRACTICAL IMPACT:

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Ito S*, Chetlapalli K*, Wang D, Potnis KC, Richmond R, Krumholz H, Lee AI, Cuker A, Goshua G.
Blood
2025
January
FEATURED
RECOGNITIONS:

Gap: Proximal complement inhibition is cost-saving for patients with suboptimal response on C5 inhibitor therapy in the United States and can be cost-saving in international jurisdictions (Penn-Yale collaboration).

PRACTICAL IMPACT:

Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource

Ito S, Pandya A, Hauser RG, Krishnamurti L, Stites E, Tormey C, Krumholz HM, Hendrickson JE, Goshua G
American Journal of Hematology
2024
April
FEATURED
RECOGNITIONS:

Gap: Supporting the mission of the 501(c)(3) Alloantibody Exchange www.alloantibody.org. 2022 ASH Press Program Selection.

PRACTICAL IMPACT:
Abstract Futuristic Background

Publications

bottom of page